Telavancin
Catalog No. A12698
Telavancin是一种半合成的万古霉素类似物,它是通过在二糖的游离氨基上添加癸基氨基乙基部分而制得的。
- Adam J Plaunt, .et al. Development and Preclinical Evaluation of New Inhaled Lipoglycopeptides for the Treatment of Persistent Pulmonary MRSA Infections, Antimicrob Agents Chemother, 2021, May 3;AAC.00316-21 PMID: 33941518
Catalog Num | A12698 |
---|---|
M. Wt | 1755.63 |
Formula | C80H106Cl2N11O27P |
Purity | >98% |
Storage | at -20°C 3 years Powder |
CAS No. | 372151-71-8 |
Synonyms | |
SMILES | CCCCCCCCCCNCCN[C@]1(C[C@@H](O[C@H]([C@H]1O)C)O[C@@H]2[C@H]([C@@H]([C@H](O[C@H]2OC3=C4C=C5C=C3OC6=C(C=C(C=C6)[C@H]([C@H](C(=O)N[C@H](C(=O)N[C@H]5C(=O)N[C@@H]7C8=CC(=C(C=C8)O)C9=C(C(=C(C=C9[C@H](NC(=O)[C@H]([C@@H](C1=CC(=C(O4)C=C1)Cl)O)NC7=O)C(=O)O)O)CNCP(= |
Telavancin是一种半合成的万古霉素类似物,它是通过在二糖的游离氨基上添加癸基氨基乙基部分而制得的。
Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
---|---|---|---|
0.1 mM | 5.7 mL | 28.48 mL | 56.96 mL |
0.5 mM | 1.14 mL | 5.7 mL | 11.39 mL |
1 mM | 0.57 mL | 2.85 mL | 5.7 mL |
5 mM | 0.11 mL | 0.57 mL | 1.14 mL |
*The above data is based on the productmolecular weight 1755.63. Batch specific molecular weights may vary from batch to batch due to solvent of hydration, which will affect the solvent volumes required to prepare stock solutions.